Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 2, Pages 611-619
Publisher
The American Association of Immunologists
Online
2016-06-18
DOI
10.4049/jimmunol.1401028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice
- (2016) Irina N. Baranova et al. JOURNAL OF IMMUNOLOGY
- Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation
- (2016) Ana Carolina P. Souza et al. KIDNEY INTERNATIONAL
- Oxidized High-Density Lipoprotein Impairs Endothelial Progenitor Cells' Function by Activation of CD36-MAPK-TSP-1 Pathways
- (2015) Jianxiang Wu et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of Human CD36 in Bacterial Recognition, Phagocytosis, and Pathogen-Induced JNK-Mediated Signaling
- (2014) I. N. Baranova et al. JOURNAL OF IMMUNOLOGY
- Mechanical induction of group V phospholipase A2 causes lung inflammation and acute lung injury
- (2013) Angelo Y. Meliton et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis
- (2013) Oleg F. Sharifov et al. PLoS One
- Class B Scavenger Receptor Types I and II and CD36 Targeting Improves Sepsis Survival and Acute Outcomes in Mice
- (2012) A. Leelahavanichkul et al. JOURNAL OF IMMUNOLOGY
- 4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats
- (2012) Woon Yong Kwon et al. Journal of Trauma and Acute Care Surgery
- Deficiency of Scavenger Receptor BI Leads to Impaired Lymphocyte Homeostasis and Autoimmune Disorders in Mice
- (2011) Hong Feng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Class B Scavenger Receptor Types I and II and CD36 Mediate Bacterial Recognition and Proinflammatory Signaling Induced by Escherichia coli, Lipopolysaccharide, and Cytosolic Chaperonin 60
- (2011) I. N. Baranova et al. JOURNAL OF IMMUNOLOGY
- The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
- (2011) Belinda A Di Bartolo et al. Lipids in Health and Disease
- Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides
- (2010) Wilissa D'Souza et al. CIRCULATION RESEARCH
- CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells
- (2010) Irina N. Baranova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 5A, an Apolipoprotein A-I Mimetic Peptide, Attenuates the Induction of House Dust Mite-Induced Asthma
- (2010) X. Yao et al. JOURNAL OF IMMUNOLOGY
- High density lipoprotein: it's not just about lipid transport anymore
- (2010) Scott M. Gordon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Toll-like receptor 4 mediates neutrophil sequestration and lung injury induced by endotoxin and hyperinflation*
- (2009) Guochang Hu et al. CRITICAL CARE MEDICINE
- Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action
- (2009) Godfrey S Getz et al. CURRENT OPINION IN LIPIDOLOGY
- Structural Basis for the Recognition of Oxidized Phospholipids in Oxidized Low Density Lipoproteins by Class B Scavenger Receptors CD36 and SR-BI
- (2009) Detao Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD
- (2009) D. M. Okamura et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide
- (2009) Nosratola D. Vaziri et al. KIDNEY INTERNATIONAL
- Host Scavenger Receptor SR-BI Plays a Dual Role in the Establishment of Malaria Parasite Liver Infection
- (2008) Cristina D. Rodrigues et al. Cell Host & Microbe
- HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
- (2008) Alan R. Tall et al. Cell Metabolism
- Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis
- (2008) Christina Charles-Schoeman et al. CLINICAL IMMUNOLOGY
- Multiple actions of high-density lipoprotein
- (2008) Matilda Florentin et al. CURRENT OPINION IN CARDIOLOGY
- Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides
- (2008) Amar A. Sethi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance
- (2008) Lei Cai et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I
- (2008) Brian J. Van Lenten et al. JOURNAL OF LIPID RESEARCH
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- (2008) LeAnne T. Bloedon et al. JOURNAL OF LIPID RESEARCH
- Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells
- (2008) H. Barth et al. JOURNAL OF VIROLOGY
- Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo
- (2007) Rajesh Puranik et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now